A new publication into the benefits of spironolactone (Prilactone - CEVA Animal Health) has supported its use as part of first-line therapy for the treatment of dogs with congestive heart failure caused by mitral heart disease, according to CEVA.
The double-blind placebo-controlled study1 involved 212 dogs on either spironolactone or a placebo, in addition to conventional therapy including an ACE inhibitor and furosemide. It revealed that over a 15 month period 25.5% of dogs either died, were euthanased or severely worsened in the placebo group compared to 10.8% in the spironolactone group. This represents a 55% reduction in the risk of cardiac morbidity-mortality and a 69% reduction in the risk of cardiac-related death or euthanasia.
Further research2 has also revealed that aldosterone antagonists, such as spironolactone, help to prevent myocardial fibrosis, a pathogenic process involved in the progression of heart failure.
For more information, 'Start Conversation' with Fraser Broadfoot MRCVS at CEVA Animal Health, or ring 01494 781510.
1 Efficacy of spironolactone on survival in dogs with naturally-occurring mitral regurgitation caused by myxomatous mitral value disease. Bernay F, Bland JM, Häggstrőm J, Baduel L, Combes B, Lopez A, Kaltsatos, V. (2010). Journal of Veterinary Internal Medicine.2 Aldosterone receptor antagonists - how cardiovascular actions may explain their beneficial effects in heart failure. Ovaert P, Elliot J, Bernay F, Guillot E, Bardon T. (2010). Journal of Veterinary Pharmacology and Therapeutics.
MDC Exports has launched a new Soft E Collar specifically designed to help greyhounds recover, post-op.
MDC says the new Soft E Collar has been designed to take into account a greyhound's long fragile neck and to make wearing a medical collar much more comfortable. It also features a drawstring design to prevent the animal from being able to back out of the collar, something the company says is a particular problem when greyhounds wear conventional collars.
According to MDC, the Soft E Collar acts as an effective barrier to a treatment area while ensuring an animal can eat, drink and sleep comfortably. It allows free movement of the head, neck and body so the animal can carry on as normal. And unlike traditional "Elizabethan" collars, the Soft E Collar is made out of soft fabric that is non-allergenic, non-toxic and water repellent. It is tough and easily able to withstand persistent clawing and chewing. Lastly, it is lightweight and very flexible, folding flat for ease of storage and springing back to its original shape when you are ready to use it.
The Soft E Collar for greyhounds is priced from £7.95. For more information visit http://www.mdcexports.co.uk/
150 graduates will get the opportunity to work in knowledge intensive companies across London and the south east following the announcement today that a joint bid by UCL and the Royal Veterinary College (RVC) has been awarded £240,000 of Government funding as part of a national scheme designed at helping young people into work.
UCL will administer some 115 internships in the digital industries, advanced manufacturing, engineering and financial services, while the RVC will deliver around 35 life science internship placements. In line with all of the HEFCE-supported work experience schemes, places on the UCL-RVC will be available to graduates of all universities, with priority being given to those that graduated last year and have yet to find stable employment and for those graduating in 2010.
The paid internship placements will help recent graduates to develop vital employability skills, through both work based learning and skills training sessions, and allow both small and large companies to preserve novel research, development and commercial projects during the economic downturn.
The award will help both institutions to build on their existing programmes. UCL already planned to offer 50 work experience places this summer following from their successful scheme, first run last year. The grant similarly allows RVC and The London BioScience Innovation Centre to continue to grow its reputation as an employer by helping life science graduates make the transition from higher education to the commercial bioscience sector through work experience placements and skills development.
Jim Gazzard, Enterprise and Technology Executive at the RVC said: "Recent graduates have much to offer knowledge intensive companies. In our experience these companies are looking to recruit talented graduates but are restricted in their ability to do so in the current economic climate. Graduate internship schemes help to solve this problem, allowing companies to continue to explore exciting commercial projects and graduates to gain a foothold in the job market while developing essential employability skills."
To date the RVC has received over 1,000 applications for 60 internship placements on its ORBIS internship scheme. This shows the significant demand from graduates seeking careers in leading bioscience and bio-veterinary companies.
The Department for Environment Food and Rural affairs has marked the 10th anniversary of the Pet Travel Scheme with the release of some interesting facts and figures...
The scheme started on 28 February 2000 when owners were first able to travel to and from the UK without placing their pets in quarantine, as long as they fulfilled certain important disease control criteria.
A pug called Frodo Baggins was the first animal to travel with a pet passport and since then, 660,000 pet journeys have been made using pet passports.
60 per cent of the pets that have travelled under the scheme belong to UK owners. Animals from Ireland, France, Germany, Belgium and the Netherlands make up about another 20 per cent.
According to Defra, the scheme was set up in response to growing demand from owners to travel with their pets, and the declining risk of disease allowed these changes to be made. In 2004 the European Union followed the UK's lead and introduced a similar system for all Member States which has also proved very successful.
Defra says the success of the scheme is fully demonstrated by the fact that it has not been associated with a single case of rabies. Animal Welfare Minister Jim Fitzpatrick said: "The Pet Travel Scheme was set up to enable British animal owners to enjoy travelling with their pets when they need to. The success of the scheme shows that responsible pet ownership makes a large contribution to managing disease risks effectively."
As rabies in Europe steadily reduces, and with EU harmonised rules continuing to successfully control rabies, Defra says it is monitoring developments in vaccination and disease management in the EU and round the world to ensure that the UK has the most effective and proportionate controls possible as circumstances continue to change.
CEVA Animal Health has added to its joint care range with the launch of Meloxidyl Injection to help control post-operative pain in cats and dogs and alleviate musculoskeletal pain in dogs.
CEVA says Meloxidyl Injection is bioequivalent to the leading meloxicam injection and dogs can be given Meloxidyl oral suspension 24 hours after Meloxidyl Injection has been administered.
Meloxidyl Injection is available in 10ml bottles containing 5mg/ml of meloxicam.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.
The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals which afford the UK additional protection against rabies, ticks and tapeworms.
The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision.
The transitional arrangements allow the UK to impose stricter measures on the entry of pet animals and are designed to protect the UK from rabies, ticks and tapeworms (Echinococcus multilocularis).
The vote in the European Parliament today supports an extension of these arrangements until the end of 2011 and puts in place a system so that permanent measures can be imposed in the future for entry to specific Member States based on scientific evidence. The decision will have to be ratified by the European Agriculture Council before coming into force.
Parasitologist Maggie Fisher from ESCCAP said: "This provides the UK with invaluable time to mount a solid scientific case for retaining the requirement for tick and tapeworm treatment indefinitely."
Professor Bill Reilly, President of the BVA, said: "The BVA and BSAVA have worked closely with Defra to secure this extension to the arrangements and we will now be pushing for investment in additional scientific research that will give us a clearer picture of the threat of the parasite Echinococcus multilocularis and other exotic and emerging diseases."
Dr Richard Dixon, President of BSAVA, added: "This decision in Europe is strongly welcomed and we are pleased that veterinary associations across Europe supported our position. The next stage is to gather further evidence to ensure the UK is protected in the future.
"In the meantime, the key message for pet owners is that they must talk to their vets as early as possible to find out how to protect them from disease and parasites when travelling abroad."
A major consultation of the National Occupational Standards required by veterinary nurses will take place throughout April 2010, giving veterinary nurses, employers and organisations the opportunity to ensure their ways of working are accurately reflected.
Lantra, the Sector Skills Council for environmental and land-based industries, is leading the UK wide project, which will lead to a revised list of skills needed for student and registered veterinary nurses to be able to do their job properly. Lantra is seeking individuals and organisations representing veterinary nursing and veterinary surgeons to participate in the online consultation and help ensure that National Occupational Standards fit modern business needs.
Lisa Jarvis, Industry Partnership Manager for veterinary nursing at Lantra and a RVN herself, said: "The National Occupational Standards identify the detailed knowledge, understanding, ability and experiences somebody needs to carry out their job effectively and they also form the basis of veterinary nursing qualifications. Industry input is critical for this review and so now is the time for you to go online and have your say."
Many employers and industry representatives from across the UK are supporting this extensive review.
Catherine Corden, a Veterinary Surgeon at the Northlands Veterinary Hospital, said: "I decided to get involved with this review so that I can actually contribute to the changes in the standards, instead of moaning about them afterwards. I think they are really important for industry as they maintain the standards of veterinary nurse training and I think industry should be getting involved with the upcoming consultation to help ensure these changes are relevant to the profession at large."
The online consultation will take place from Thursday 1 April to Friday 30 April, and will give all those interested parties the opportunity to review and comment on the standards for veterinary nurses.
Lisa said: "National Occupational Standards cannot be developed without your help. Only by working together can we ensure that the revised Standards will take into account any new business practices and make them fit for purpose and valued by employers."
To take part in the consultation and help industry get the most out of the skills system, visit www.lantra.co.uk/vn-nos. For more information about National Occupational Standards, email standardsandquals@lantra.co.uk, or call Lantra on 02476 858 424.
Virbac has launched a reformulated dental chew for dogs.
The company says the new VeggieDent chew is thicker in order to prolong the chewing time, but retain its palatability and characteristic Z shape, designed to facilitate prehension and enhance the mechanical cleaning action.
Product manager Chris Geddes MRCVS says the longer chewing time means increased contact between teeth and chew: "Optimum plaque removal is achieved by physical abrasion of the tooth surface during chewing. What is important is both the nature and the duration of contact between tooth and chew. These chews have been reformulated to optimise both of these factors.
"Whilst regular tooth brushing is always the gold standard, the chews provide enhanced plaque removal above brushing alone, and are particularly suited for those difficult cases where brushing is not possible".
"Many dogs are offered treats or chews during the day with limited nutritional or health benefits. VeggieDent chews are highly palatable, natural, and meat-free. They help to sustain tooth and gum health and are a great way to encourage the provision of treats that have a health benefit".
The chews are available in packs of 15 in sizes suitable for small, medium and large dogs and can be obtained from your veterinary wholesaler. Look out for a relaunch promotion coming soon. For further information please speak to your Virbac Territory Manager, phone Virbac on 01359 243243, or email enquiries@virbac.co.uk.
Janssen Animal Health has released the results of a survey which suggests incorrect worming strategies on many pig units in the UK are costing the industry dearly.
Most state they do not worm weaners, growers or finishing pigs at all and, while most sows are wormed, only a third treat newly-arrived gilts and boars in quarantine.
Phil Macdonald, UK and Ireland pig business manager at Janssen said: "Worm infestations can harm growth rate and feed efficiency, they can reduce abattoir returns and increase the cost of medication".
According to the company, the survey responses point to confusion among some producers on what constitutes a strategic worming programme. Most, 68 per cent, state they have implemented strategic programmes, but fewer than two-thirds of these cover all pigs on a unit and even fewer correctly base their programmes on the pre-patent period of worms.
Phil said: "It's important that all pigs on a unit are covered by the programme, otherwise there is a higher potential for reinfection. To be effective, the anthelmintic treatment periods need to be based on the pre-patent period of worms, so that treatment interrupts their life cycle.
"It requires a strategic worming programme with a broad spectrum anthelmintic such as Flubenol and Solubenol 100mg/g, which is the first and only water-soluble benzimidazole in the market. These are effective against larvae and worm eggs of a number of worm species as well as the large roundworm, Ascaris suum. Migrating larvae of the large roundworm cause Milk Spot lesions in pig livers, which are damaging to animal welfare and unit economics."
The make-up of UK units in the survey was 58 per cent breeder/finisher, 39 per cent finisher, 3 per cent weaner/finisher. Most, 68 per cent, use dry pelleted feed, 16 per cent wet feed and 16 per cent have both feed systems.
There is wide variation in worming programmes among producers. Most breeders worm their sows - 17 per cent once a year, 56 per cent twice and 11 per cent three times. With boars, 28 per cent worm them once a year, 44 per cent twice and 11 per cent three times. But only one-third (34 per cent) of breeders worm newly-arrived gilts and boars in quarantine.
72 per cent of producers with breeding sows who responded do not worm weaners and 80 per cent do not worm growers. Of the total responses, including specialist finishers, 68 per cent do not worm finishing pigs.
Most producers, 81 per cent, stated that they are aware that livers with Milk Spot lesions have to be trimmed or totally condemned, adding significant annual costs for disposal.
68 per cent admit to Milk Spot lesion levels of 25 per cent in consignments of pigs. Another 10 per cent experience up to 75 per cent livers with Milk Spot damage, and 3 per cent have had every pig liver in a consignment trimmed or condemned because of lesions. The feedback to producers comes from the BPEX Pig Health Scheme, of which 88 per cent of producers are members.
Only 58 per cent of producers are aware that more traditional worming methods allow pigs continuously to reinfect each other and their environment. Traditional programmes do not take the worm's life cycle into account.
The detrimental effect of worm damage that causes most concern to producers is lost growth/poorer feed conversion (29 per cent). Others considered the most important to be:
Phil says research shows that losses in daily liveweight gain alone add up to £2.31 per slaughter pig where liver condemnations are 30 per cent. "The frightening fact is that the loss is for every slaughter pig, not just those with Milk Spot lesions.
"In a 300-sow herd producing 23 pigs per sow per year that's a loss of £15,939 a year. On a 1,000-sow unit that exceeds a horrendous £53,000 annually, and these figures take no account of other areas of loss mentioned."
An adult female worm can shed hundreds of thousands of eggs each day, which pigs pass out in their dung. Worm eggs can remain infective for up to 10 years. Other pigs ingest them and the reinfection process begins.
Phil said: "A strategic worming programme that treats all pigs on a unit simultaneously is the only effective way to almost completely eliminate the problem. The survey has shown there is considerable potential for a large proportion of producers to improve productivity and cut costs by focusing on this critical area of management."
Vetoquinol has announced the launch of its new support package to help vets and owners manage canine epilepsy with Epiphen, the company's phenobarbital medication.
Each Epiphen support package contains:
Accurate information is vital to help control epilepsy patients and the Owner Record Manual will enable owners to keep on top of this information. It contains charts to monitor seizure frequency and patterns, medication changes, blood test results and seizure characteristics.
The new "ask the expert" scheme offers vets the opportunity to ask for advice on epilepsy cases. Email epiphen@vetoquinol.co.uk with the query (and your contact details) and you will be put in touch with a neurology expert at a leading referral centre. Vets can also contact the Technical Helpline on 0800 1698197.
The Seizure Reports for vets provide a much more detailed tool for use at initial presentation or for owners to fill in when seizures differ in character. There is a pad of 30 tear-off sheets in each Epiphen support package.
Simon Boulton, Epiphen product manager said: "We understand that epilepsy is an emotional condition and wanted to provide vets and owners with more than just a tablet. I am convinced that with the Epiphen Support Package we are providing them with the tools they need to make the most of epilepsy management."
Epiphen also offers a free phenobarbital monitoring service. There is a voucher in each 30mg pack and 2 in each 60mg pack.
For more details on the Epiphen Support Package, to obtain a free practice starter pack or get extra copies of materials, please contact Vetoquinol on 0800 1608197 or contact your Vetoquinol representative.
Janssen Animal Health is advising vets to be on the look out for coccidiosis as the spring lambing season approaches: cases usually rise in March and peak in April and May.
According to the company, some reports also suggest that the incidence of coccidiosis in calves may apparently increase during the grazing months. However, vets are reporting that interpretation of laboratory tests used to confirm diagnosis, such as oocyst count, can be problematic due to the ubiquitous nature of the Eimeria parasite in the UK.
Young animals may be infected by oocysts shed by asymptomatic carriers or infected older cohort animals. Low levels of challenge can help young animals develop immunity but exposure to high oocyst numbers, particularly in combination with stress can lead to clinical and subclinical forms of the disease. Diagnosis can be problematic, particularly in subclinical cases of disease where failure to gain weight is the main presenting sign and in clinical cases the differential diagnoses include all causes of scour in young animals.
Janssen Animal Health has suggested a few indicators that may be useful in identifying cases of coccidiosis. The Vecoxan Coccidiosis Survey in 2008 and 2009 asked farmers about their experiences of coccidiosis and identified that bad weather was a major trigger particularly in lambs; while castration and weaning were also factors in calves. As the parasite life cycle is 21 days, vets should be alert to disease 2-3 weeks after a stressor event.
The company has also suggested a few guidelines to aid interpretation of laboratory results:
Janssen says Vecoxan (diclazuril) does not interfere with the development of immunity and kills all stages of the parasite in the host.
Hill's Pet Nutrition has announced an average price reduction of over 5 per cent across almost 80 per cent of its product range from 1st March 2010.
The company says this is the first time in its history that such a big price reduction has been implemented, and it comes with a promise that superior nutritional quality won't be compromised.
The price cut comes following market research by Hill's which shows that after one of the deepest recessions in 50 years, more pet owners are becoming cost-conscious, and many are now buying their petfood in the grocery channel or mixing premium foods with economy products.
Another factor in decision-making for some pet owners is the cost per pack, particularly on the larger bag sizes. From April 2010, some Hill's Prescription Diet products will be resized to make them a more affordable purchase. Canine Prescription Diets c/d, d/d, i/d, k/d and j/d will be moved from a 14 Kg bag to a 12 Kg bag. Feline Prescription Diets c/d, k/d, r/d, i/d and s/d will be moved from a 2 Kg bag to a 1.5 kg bag. The price reduction will also be applied proportionately alongside the smaller bag size, so many clients should see a significant reduction at point of purchase. The smaller bags are also easier for practices to store and can increase frequency of client visits providing more opportunities to offer advice and support.
Blake Hawley, Hill's General Manager for UK and Ireland said, "We would like to thank vets, nurses and support staff for their continued support and dedication. Every pet needs and deserves a nutritional assessment and this price reduction will make it easier for vet teams to recommend the best Hill's product, confident those pets are getting high quality nutrition at new, lower prices. Having listened to what the profession had to say in 2009, this year we will demonstrate our commitment to the veterinary profession in very clear and visible ways."
For an up to date price list and support material to assist in communicating the change to clients, please contact your Hill's Territory Manager or call 0800 282438
A rural social scientist has argued in this week's Veterinary Record that the dwindling influence of vets in the public health arena threatens food safety in the UK. Philip Lowe, from the Centre for Rural Economy at the University of Newcastle, argues that a shift in practice from treating animals used for food on farms to looking after pets in urban communities, is largely to blame. The proportion of time vets in private practice spent treating animals used for food halved between 1998 and 2006. Most vets run their own businesses, and pet owners have proved a more sustainable and lucrative source of income than farmers. Professor Lowe sympathises with the need to make money, but laments this drift towards the profession turning into "another private sector service industry." He says this fails to make use of vets' considerable and wide ranging expertise, adding: "I would argue that it also diminishes the public standing of the whole profession. I certainly couldn't imagine the medical establishment in this country accepting a role that marginalised public health, even if the NHS did not exist. More seriously for all of us, I believe that not involving vets in this important area also puts food safety in the UK at risk. "At the same time we live in an age when there is real and widespread public concern about welfare standards for farm animals, threats from animal diseases old and new (such as blue tongue, bird flu and swine flu), and food safety." Professor Lowe says that in the past, the veterinary arm of government traditionally provided leadership for the profession that was embodied by the Chief Veterinary Officer and was underpinned by the proportion of vets' income derived from public funding. But this is no longer the case, and is further undermined by the percentage of vets employed by government having shrunk from 11% to 4% over the past 40 years. Professor Lowe argues that the profession needs to rethink its role and the direction in which it is travelling. He says there needs to be more specialist support and training for student vets and novice practitioners so that they are not put off from farm practice before they have had a chance to develop their skills and confidence in this area. However, he cautions against returning to the stereotype popularised by the fictional James Herriot vet, who was depicted as a mainstay of the rural community: "The farm vet's position and respect for their expertise needs to be restored, but not in the old Herriot mould. He or she has to take on the much greater challenge of risk and welfare regulation and management across the whole food system".
Veterinary Nurse Nick Shackleton has started a campaign to protect the title Veterinary Nurse
The campaign has a section on Facebook where Nick explains: "The title veterinary nurse at present is not a protected title. A lot of people who work in practice call them selves veterinary nurse, when they have no theoretical training in such a position. As qualified nurses we feel that this issue should be addressed so that the general public are no longer confused as to the qualification and hopefully make them more aware of the hard work it is to gain the qualification. As we are heading for autonomy within the profession I think it is right and fitting that the title should be protected."
The group has already gained an impressive 781 members.
In addition, Nick has started a petition on the Prime Minister's website: Number10.gov.uk, which has gained 139 signatories so far.
If you'd like to sign the petition on Number10.gov.uk, I recommend you add the letters after your name (MRCVS / RVN).
Hill's has added to its range of Science Plan Snacks with a large biscuit size, big bag version for large breed dogs. The 400 gram packs are available as Large Breed Light and Large Breed Healthy Mobility Snacks at a launch price of £2.49 (normal recommended retail price £4.99).
The company says that this follows fantastic feedback from veterinary practices about Science Plan Snacks, and requests for more variants tailored to fit the needs of their client's pets.
The Science Plan snack range offers products across five areas of functionality which, according to Hill's, have proven to be highly motivating for clients: light, immunity support, healthy mobility, oral care and skin & coat. There are adult variants across the range and puppy variants in immunity support and skin & coat.
For further information, please contact your Hill's Territory Manager or Hill's customer service on 0800 282438.
Bayer Animal Health is currently sponsoring GMTV's Pet Clinic feature to promote its wormer, Drontal.
Running until Friday 19 February, the All About Pets short programmes feature TV vet Emma Milne who will be advising viewers on a variety of topics from choosing the right pet to hidden illnesses.
All About Pets will be aired twice daily and Drontal will be featured after the short programmes.
Bayer says the advertising will target the product's core target audience - housewives with children during half term - with key messages on the importance of regular worming with Drontal. In addition, GMTV will also include details on Drontal on its website - www.gm.tv - and pet owners will be able to follow a link to the award-winning website www.drontal.com.
Novartis Animal Health has launched a chewable formulation of Milbemax wormer, for dogs.
According to the company, clinical studies have shown that the chicken-flavoured formulation and chewy texture of Milbemax Chewable Tablets is highly palatable, with more than 94% of dogs showing spontaneous acceptance from hand. Novartis says this should help make worming simpler and improve compliance, something which is particularly important given market research which shows that difficulties in administering medications often leads to missed treatments.
Containing milbemycin oxime and praziquantel, the new tablets deliver the same broad spectrum efficacy as existing Milbemax formulations, effective for the treatment of roundworm, hookworm, whipworm, lungworm and tapeworm, and for the prevention of heartworm.
Folkert Kamphuis, Chief Operating Officer at Novartis Animal Health said: "The new EASYCHEW™ formulation represents Novartis Animal Health's latest innovation. It will make worming a treat whilst providing tried-and-trusted Milbemax efficacy. With Milbemax chewable tablets we give pet owners a wormer that is easy to administer and veterinarians the trusted efficacy of Milbemax."
Milbemax Chewable Tablets are available for both dogs and puppies, in four and forty-eight tablet packs.
Somerset-based veterinary wholesaler, Centaur Services has been bought by US veterinary distributor MWI Veterinary Supply Inc.
According to MWI (the letters stand for Millard Wallace Ickes, the name of the company's founder), the transaction is valued at approximately $47 million, consisting of $45 million in cash and $2 million in a note payable in one year.
Jim Cleary, President and Chief Executive Officer of MWI, said: "MWI has positioned itself to continue its growth within the United States and now internationally. Centaur is a high-quality company that will allow us to serve veterinarians in the United Kingdom. We believe that it will be a great partnership and one that will bring further growth opportunities. We welcome the Centaur team to MWI."Paul Gerring, Managing Director of Centaur, commented: "We are looking forward to working with a strong company that has a great reputation in the animal health industry. Our team is excited to develop this relationship and be part of a company with proven success. Both Centaur and MWI are focused on providing high levels of customer service to veterinarians."
CEVA Animal Health is rolling out what it describes as a hard-hitting TV campaign on four national TV channels to highlight awareness of stress related feline behaviour problems and encourage cat owners to talk to their vet about Feliway.
This second bout of TV advertising will run in March and April on ITV2, ITV3, E4 and More 4 and on Channel 4 in the London region and will be seen by over five million people.
Featuring the animated character 'That Purple Cat' who first appeared in CEVA's TV advertising and marketing push at the end of 2009, the new campaign will see 'That Purple Cat' displaying signs of stress in the home environment to raise awareness of the issue amongst cat owners.
Lucy Brett, product manager at CEVA Animal Health said: "Our first TV advertising campaign back in the autumn went a long way to raise awareness. We found that more cat owners were able to recall the advertising for Feliway than for any other animal health brand.
"However, it is clear that in practice merchandising is crucial if practices are to make the most of this opportunity and I would encourage them to get in touch to request a display pack, which includes a waiting room poster and leaflets, as soon as possible."
A limited number of desktop and floor standing merchandising units are also available. For more information or to order your FREE waiting room merchandising materials call 01494 781510.
Virbac Animal Health has launched a new pet owner information pack to help practices raise awareness of reproductive health issues in dogs and cats.
The pack consists of a leaflet holder with four different leaflets covering unwanted sexual behaviour, castration, prostate disease and misalliance. The holder has a small footprint so will sit nicely in any practice reception area.
Product manager Chris Geddes MRCVS says that the pack will make it easier for vets and VNs to raise the sensitive issue of pet reproductive health with owners. "For example, prostate disease in men is well documented and public knowledge is high, but we believe that few people know that it can affect pets too.
"It is estimated that 80% of male dogs over the age of five suffer from prostate problems, but experts agree that it is underdiagnosed at present. This is possibly due to a combination of a lack of awareness and client unease on discussing reproductive subjects at their vet practice."
To obtain your free pack or for further information, please contact your local territory manager or call Virbac on 01359 243243.
Intervet/Schering-Plough Animal Health has announced that it has received marketing authorization from the European Commission for a single-shot vaccination schedule of its Porcilis PCV vaccine against porcine circovirus type 2 (PCV2) infections.
The new approval allows vaccination with 1 dose of 2 ml in pigs from an age of 3 weeks onwards (known as the 1 - 2 - 3 approach) in the case of low to medium levels of maternal antibodies against PCV2, and also to include reduction of mortality as an additional indication. This new single-shot application for Porcilis PCV offers additional flexibility over the currently available dosage scheme of this vaccine, which has been available in Europe since April 2009.
Intervet/Schering Plough says the major characteristics of Porcilis PCV are that: (1) it contains the Cap-2 subunit antigen coded by ORF2 and therefore induces strong immunity against PCV2 infection; (2) it is combined with XSolve, an adjuvant offering immunity until the end of the finishing period; and (3) is able to break through of all levels of maternally-derived antibodies in piglets depending on the vaccination schedule used.
The company adds that one single dose of Porcilis PCV has been demonstrated to induce both humoral and cell-mediated responses against PCV2, despite the presence of low to medium levels of maternal antibodies. According to a recent study published in Vaccine, the immunity induced by a single dose of the vaccine resulted in reductions of viremia, viral shedding and viral load in tissues in vaccinated pigs as compared to controls. Field trials have also demonstrated that vaccination of pigs at 3 weeks of age or older reduces the presence of virus load in the blood and reduces weight loss associated with PCV2 infection during the fattening period.
Infection with PCV2 is known to cause a variety of syndromes in pigs, together known as Porcine Circo Virus Disease (PCVD). Symptoms may include clinical signs such as weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, pale skin and jaundice.
The National Association of Veterinary Physiotherapists (NAVP) is calling for the Royal College of Veterinary Surgeons (RCVS) to establish an independent register of veterinary physiotherapy practitioners. According to the Association, such a register would eliminate individuals practicing without proper training and qualifications and raise the standard of veterinary physiotherapy by providing a disciplinary role.
NAVP President and leading veterinary anatomist Dr Sue Kempson is heading the NAVP campaign for the establishment of an independent register. In a letter to the President of the RCVS, Dr Kempson said: "Recognition by the veterinary profession of the role of physiotherapy in post-operative rehabilitation and in supporting both companion and performance animals is growing. However, we do believe that referring veterinary surgeons are increasingly faced with a dilemma caused by the wide differential between qualifications offered by the various organisations representing practitioners in areas such as physiotherapy. There is an urgent need for a distinction to be made between these different types of qualification. To this end, there should be a clearly defined independent register of practitioners with appropriately validated qualifications which are clearly understood by the veterinary profession."
In partnership with Harper Adams University College, the NAVP has introduced a fully-validated post-graduate course in veterinary physiotherapy which offers a choice of Post-Graduate Diploma or Masters Degree. Only one other professional body, the Association of Chartered Physiotherapists in Animal Therapy (ACPAT) currently offers a similar qualification at this level.
Dr Kempson said: "The establishment of a register of physiotherapists would greatly assist vets and their clients to make informed decisions on their choice of therapist. It would eliminate those individuals without proper training and qualifications and help raise the standard of veterinary physiotherapy by providing a disciplinary role. At present there are no sanctions on those people practicing without the necessary qualifications or those whose work is sub-standard or who are guilty of professional misconduct.
"We do not believe that such a register should rest with any individual professional body or be affiliated to specific educational courses. To have authority, it requires independence and a register held under the auspices of the Royal College of Veterinary Surgeons would carry the credibility that the veterinary profession requires."
Eurovet Animal Health Ltd has entered the UK veterinary pharmaceuticals market with a portfolio of products including a levothyroxine tablet for the treatment of canine hypothyroidism, injectables for cattle and pigs, a xylazine injection for use in cattle, horses, dogs & cats and a corticosteroid for use in horses, cattle, pigs, cats and dogs.
Eurovet Animal Health is a subsidiary of Dutch company, AUV, which was established in 1969 as a cooperative by 100 veterinary surgeons, and is now jointly owned by 2000 vets. The company says this gives it a unique perspective on the products that veterinary surgeons really need and want. And whilst Eurovet Animal Health is still relatively small in the UK, the parent company Eurovet Animal Health BV owns state-of-the-art manufacturing facilities and provides access to international expertise, support and resources.
Eurovet Animal Health Ltd will be offering Eurovet products previously distributed by partner companies in the UK, so vets can expect to see brands they know and trust, as well as new brands. Existing products will be available from veterinary wholesalers and include:
Further information about Eurovet's range of products is available from Eurovet Animal Health, Compass House, Chivers Way, Histon, Cambridge, CB24 9AD Tel: 01223 257933 E-mail office@eurovet-ah.co.uk http://www.eurovet-ah.co.uk/
Novartis Animal Health has launched Zolvix, billed as the first truly novel anthelmintic class for livestock to be launched in more than 25 years, together with a new drenching system designed to make drenching faster, easier and more accurate.
Zolvix contains a new active ingredient, monepantel, which kills all key sheep gastro-intestinal nematodes (roundworms), including those resistant to the existing treatments.
According to the company, the development of this new drench follows the persistent challenge from worms that have developed resistance to the three other classes of drench - white (benzimidazole or 1-BZ), yellow (levamisole or 2-LV) and clear (macrocyclic lactone or 3-ML) and combinations of these. Zolvix has a unique mode of action and so forms a fourth generation of anthelmintic, which will be known as the 4- AD, or orange drench class
Novartis Animal Health has prioritised the UK and Ireland as key launch countries for Zolvix to provide their sheep farmers with an answer to the pressing challenge of increasing anthelmintic resistance.
Lesley Stubbings, an Independent sheep consultant and Sustainable Control of Parasites in Sheep (SCOPS) panel member, said: "Resistance has become an ever increasing threat since the last new anthelmintic group was introduced to the UK market more than 25 years ago. Zolvix offers farmers a valuable opportunity to maintain good worm control and prolong the effective life of the existing products. Following the SCOPS guidelines to carefully integrate Zolvix into worm control strategies, before the other groups fail, will allow our sheep industry to reap the full benefits of this new novel group."
A study carried out by Novartis in conjunction with the Hopkirk Research Institute showed that Zolvix treated sheep gained 33.5%, or 2.8 kg deadweight, more than sheep treated with a drench to which they were resistant.
Novartis Animal Health Brand Manager Simon Harris said: "Parasite resistance is a growing problem that decreases the productivity of sheep of all ages. Many veterinarians and farmers are concerned about this, with an increasing number of farmers reporting resistance to the three groups of wormers that have been available up to now, so the introduction of Zolvix is very timely."
At the same time, the company has also launched an award-winning new drenching system designed to offer 'a superior drenching experience for both animal and operator'. The new Optiline Drencher and Optivix backpack system were developed in collaboration with drenching specialists Simcro Tech Ltd.
The Optiline Drencher has already won several design and engineering awards, including a bronze award in the 2009 NZ BEST design awards, a coveted International Forum (IF) 2010 product design award from Germany and the prestigious Bayer Innovators Award for design and engineering.
It was also a finalist in the New Zealand Agritech Innovation Awards reached the finals in three categories of the 2009 New Zealand Trade and Enterprise International Business Awards.
The Optiline drencher is coupled with a durable, light Optivix backpack that has been specially tailored to provide left or right-handed operators with the same wide range of adjustment. It also has two drench cradles - at chest and hip level - to ensure maximum comfort.
Mr Harris said: "This drencher is best appreciated during use. Contact your local Novartis Animal health representative to arrange a trial."